Resilience of melanoma diagnostics at a tertiary-care hospital during the SARS-CoV-2 pandemic

• Soma Jobbagy, MD, PhD,
• Kristine M. Chaudet, MD,
• Matthew Gayhart, MD,
• Veronica E. Klepeis, MD, PhD,
• Genevieve Boland, MD, PhD,
• Hensin Tsao, MD, PhD,
• Lyn M. Duncan, MD

Affiliations

Soma Jobbagy, MD, PhD

Pathology Service, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts

Kristine M. Chaudet, MD

Pathology Service, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts

Matthew Gayhart, MD

Pathology Service, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts

Veronica E. Klepeis, MD, PhD

Pathology Service, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts

Genevieve Boland, MD, PhD

Harvard Medical School, Boston, Massachusetts; Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts

Hensin Tsao, MD, PhD

Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts

Lyn M. Duncan, MD

Pathology Service, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Correspondence to: Lyn M. Duncan, MD, Dermatopathology Service, Massachusetts General Hospital/Harvard Medical School, 55 Fruit St, WRN 825, Boston, MA 02114